Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-20-026177
Filing Date
2020-05-19
Accepted
2020-05-19 16:31:35
Documents
5
Effectiveness Date
2020-05-19

Document Format Files

Seq Description Document Type Size
1 S-8 achv-s8.htm S-8 237442
2 EX-4.11 achv-ex411_36.htm EX-4.11 159364
3 EX-5.1 achv-ex51_6.htm EX-5.1 13320
4 EX-23.2 achv-ex232_7.htm EX-23.2 2583
5 GRAPHIC gnbngcna2s35000001.jpg GRAPHIC 7733
  Complete submission text file 0001564590-20-026177.txt   424741
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-238505 | Film No.: 20894094
SIC: 2835 In Vitro & In Vivo Diagnostic Substances